{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/XERS/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-14T23:56:26.043Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9888,"canonical_name":"Xeris Biopharma Holdings, Inc.","cik":"0001867096","uei":null,"lei":null,"duns":null,"ticker":"XERS"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":48},"count":48,"timeline":[{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — Xeris Biopharma Holdings, Inc. — 2026-10-02","url_slug":"/sec/cik-0001867096/4/0001867096-26-000085","accession_number":"0001867096-26-000085","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — Xeris Biopharma Holdings, Inc. — 2026-10-02","url_slug":"/sec/cik-0001867096/4/0001867096-26-000086","accession_number":"0001867096-26-000086","importance":30},{"ts":"2026-09-29","kind":"sec.filing","form_type":"4","title":"4 — Xeris Biopharma Holdings, Inc. — 2026-09-29","url_slug":"/sec/cik-0001867096/4/0001867096-26-000078","accession_number":"0001867096-26-000078","importance":30},{"ts":"2026-09-28","kind":"sec.filing","form_type":"144","title":"144 — Xeris Biopharma Holdings, Inc. — 2026-09-28","url_slug":"/sec/cik-0001867096/144/0001950047-26-009839","accession_number":"0001950047-26-009839","importance":30},{"ts":"2026-09-09","kind":"sec.filing","form_type":"8-K","title":"8-K — Xeris Biopharma Holdings, Inc. — 2026-09-09","url_slug":"/sec/cik-0001867096/8-k/0001867096-26-000077","accession_number":"0001867096-26-000077","importance":35},{"ts":"2026-09-01","kind":"sec.filing","form_type":"4","title":"4 — Xeris Biopharma Holdings, Inc. — 2026-09-01","url_slug":"/sec/cik-0001867096/4/0001875714-26-000012","accession_number":"0001875714-26-000012","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"4","title":"4 — Xeris Biopharma Holdings, Inc. — 2026-09-01","url_slug":"/sec/cik-0001867096/4/0002031695-26-000011","accession_number":"0002031695-26-000011","importance":30},{"ts":"2026-08-21","kind":"sec.filing","form_type":"4","title":"4 — Xeris Biopharma Holdings, Inc. — 2026-08-21","url_slug":"/sec/cik-0001867096/4/0001867096-26-000069","accession_number":"0001867096-26-000069","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"144","title":"144 — Xeris Biopharma Holdings, Inc. — 2026-08-12","url_slug":"/sec/cik-0001867096/144/0001950047-26-008033","accession_number":"0001950047-26-008033","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"4","title":"4 — Xeris Biopharma Holdings, Inc. — 2026-08-12","url_slug":"/sec/cik-0001867096/4/0001875714-26-000009","accession_number":"0001875714-26-000009","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Xeris Biopharma Holdings, Inc. — 2026-08-06","url_slug":"/sec/cik-0001867096/10-q/0001867096-26-000065","accession_number":"0001867096-26-000065","importance":45},{"ts":"2026-08-06","kind":"sec.filing","form_type":"8-K","title":"8-K — Xeris Biopharma Holdings, Inc. — 2026-08-06","url_slug":"/sec/cik-0001867096/8-k/0001867096-26-000063","accession_number":"0001867096-26-000063","importance":35},{"ts":"2026-08-04","kind":"sec.filing","form_type":"4","title":"4 — Xeris Biopharma Holdings, Inc. — 2026-08-04","url_slug":"/sec/cik-0001867096/4/0001867096-26-000059","accession_number":"0001867096-26-000059","importance":30},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Hecht Beth","title":"See Remarks","shares":16666,"price_per_share":8.0135,"usd_value":133553,"security_title":"Common Stock","importance":35.133552991},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"McCulloch Kevin","title":"See Remarks","shares":15000,"price_per_share":8.016,"usd_value":120240,"security_title":"Common Stock","importance":35.12024},{"ts":"2026-07-31","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Xeris Biopharma Holdings, Inc. — 2026-07-31","url_slug":"/sec/cik-0001867096/schedule-13g/0002100119-26-001430","accession_number":"0002100119-26-001430","importance":55},{"ts":"2026-07-17","kind":"sec.filing","form_type":"8-K","title":"8-K — Xeris Biopharma Holdings, Inc. — 2026-07-17","url_slug":"/sec/cik-0001867096/8-k/0001867096-26-000055","accession_number":"0001867096-26-000055","importance":35},{"ts":"2026-07-07","kind":"sec.form144","reporter":"STEVEN PIEPER","title":"Officer","shares":27600,"usd_value":231012,"security_title":"Common","approx_sale_date":"2026-07-07","accession_number":"0001950047-26-006941","importance":40.0462024},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"Pieper Steven","title":"See Remarks","shares":27600,"price_per_share":8.5245,"usd_value":235276,"security_title":"Common Stock","importance":35.2352762},{"ts":"2026-07-07","kind":"sec.filing","form_type":"144","title":"144 — Xeris Biopharma Holdings, Inc. — 2026-07-07","url_slug":"/sec/cik-0001867096/144/0001950047-26-006941","accession_number":"0001950047-26-006941","importance":30},{"ts":"2026-07-07","kind":"sec.filing","form_type":"4","title":"4 — Xeris Biopharma Holdings, Inc. — 2026-07-07","url_slug":"/sec/cik-0001867096/4/0001875714-26-000007","accession_number":"0001875714-26-000007","importance":30},{"ts":"2026-07-06","kind":"sec.form144","reporter":"STEVEN PIEPER","title":"Officer","shares":17400,"usd_value":144072,"security_title":"Common","approx_sale_date":"2026-07-06","accession_number":"0001950047-26-006884","importance":40.0288144},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Pieper Steven","title":"See Remarks","shares":17400,"price_per_share":8.5,"usd_value":147900,"security_title":"Common Stock","importance":35.1479},{"ts":"2026-07-06","kind":"sec.filing","form_type":"144","title":"144 — Xeris Biopharma Holdings, Inc. — 2026-07-06","url_slug":"/sec/cik-0001867096/144/0001950047-26-006884","accession_number":"0001950047-26-006884","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — Xeris Biopharma Holdings, Inc. — 2026-07-02","url_slug":"/sec/cik-0001867096/4/0002031695-26-000008","accession_number":"0002031695-26-000008","importance":30},{"ts":"2026-07-01","kind":"sec.form144","reporter":"KEVIN MCCULLOCH","title":"Officer","shares":120000,"usd_value":950400,"security_title":"Common","approx_sale_date":"2026-07-01","accession_number":"0001950047-26-006705","importance":40.19008},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"McCulloch Kevin","title":"See Remarks","shares":90000,"price_per_share":8.0279,"usd_value":722511,"security_title":"Common Stock","importance":35.722511},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Hecht Beth","title":"See Remarks","shares":16666,"price_per_share":8.0319,"usd_value":133860,"security_title":"Common Stock","importance":35.1338596454},{"ts":"2026-07-01","kind":"sec.filing","form_type":"144","title":"144 — Xeris Biopharma Holdings, Inc. — 2026-07-01","url_slug":"/sec/cik-0001867096/144/0001950047-26-006705","accession_number":"0001950047-26-006705","importance":30},{"ts":"2026-07-01","kind":"sec.insider.a","reporter":"KREHER NERISSA","title":null,"shares":33582,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-30","kind":"sec.filing","form_type":"8-K","title":"8-K — Xeris Biopharma Holdings, Inc. — 2026-06-30","url_slug":"/sec/cik-0001867096/8-k/0001867096-26-000048","accession_number":"0001867096-26-000048","importance":35},{"ts":"2026-06-11","kind":"sec.filing","form_type":"8-K","title":"8-K — Xeris Biopharma Holdings, Inc. — 2026-06-11","url_slug":"/sec/cik-0001867096/8-k/0001867096-26-000045","accession_number":"0001867096-26-000045","importance":35},{"ts":"2026-06-05","kind":"sec.filing","form_type":"8-K","title":"8-K — Xeris Biopharma Holdings, Inc. — 2026-06-05","url_slug":"/sec/cik-0001867096/8-k/0001867096-26-000034","accession_number":"0001867096-26-000034","importance":35},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Xeris Biopharma Holdings, Inc. — 2026-06-05","url_slug":"/sec/cik-0001867096/4/0001916987-26-000004","accession_number":"0001916987-26-000004","importance":30},{"ts":"2026-06-04","kind":"sec.form144","reporter":"DAWN HALKUFF","title":"Director","shares":20000,"usd_value":117800,"security_title":"Common","approx_sale_date":"2026-06-04","accession_number":"0001950047-26-005664","importance":40.02356},{"ts":"2026-06-04","kind":"sec.form144","reporter":"Barbara-Jean Bormann-Kennedy","title":"Director","shares":16000,"usd_value":94240,"security_title":"Common","approx_sale_date":"2026-06-04","accession_number":"0001950047-26-005661","importance":40.018848},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"HALKUFF DAWN","title":null,"shares":20000,"price_per_share":6.0943,"usd_value":121886,"security_title":"Common Stock","importance":35.121886},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"BORMANN-KENNEDY BARBARA-JEAN ANNE","title":null,"shares":16000,"price_per_share":6.0942,"usd_value":97507,"security_title":"Common Stock","importance":35.0975072},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"JOHNSON JOHN","title":null,"shares":15000,"price_per_share":6.0948,"usd_value":91422,"security_title":"Common Stock","importance":35.091422},{"ts":"2026-06-04","kind":"sec.insider.a","reporter":"PERSKY MARLA","title":null,"shares":24193,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-04","kind":"sec.insider.a","reporter":"JOHNSON JOHN","title":null,"shares":24193,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-04","kind":"sec.insider.a","reporter":"Kong Garheng","title":null,"shares":24193,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-04","kind":"sec.insider.a","reporter":"BORMANN-KENNEDY BARBARA-JEAN ANNE","title":null,"shares":24193,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-04","kind":"sec.insider.a","reporter":"HALKUFF DAWN","title":null,"shares":24193,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-04","kind":"sec.insider.a","reporter":"Brady James Aloysius","title":null,"shares":24193,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.form144","reporter":"MARLA PERSKY","title":"Director","shares":15500,"usd_value":93000,"security_title":"COMMON","approx_sale_date":"2026-06-03","accession_number":"0001950047-26-005565","importance":40.0186},{"ts":"2026-06-03","kind":"sec.insider.s","reporter":"PERSKY MARLA","title":null,"shares":15500,"price_per_share":5.8989,"usd_value":91433,"security_title":"Common Stock","importance":35.09143295},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Hecht Beth","title":"See Remarks","shares":16667,"price_per_share":6.0588,"usd_value":100982,"security_title":"Common Stock","importance":35.1009820196}]}